These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

International Society for Pharmacoeconomics and Outcomes Research Europe 2025

Glasgow, Scotland, UK Nov 9 - 12, 2025

Results 1

Poster Presentation | Nov 9, 2025

Real-World Treatment Patterns Among Patients With Relapsed or Refractory (R/R) NPM1-Mutated (NPM1m) Acute Myeloid Leukemia (AML) in the United States

Gahlon G, et al.

View Material

Link to Third-Party Site

The link you have selected will take you to a separate website not owned or controlled by Syndax Pharmaceuticals, Inc. Syndax does not recommend, endorse, or make any representation regarding the content on any third-party websites.